CPT code 83013 – Helicobacter pylori urea breath test analysis

Key takeaways

CPT code 83013 covers breath specimen analysis only, while the urea drug administration bills separately under CPT 83014.

The 13C urea breath test is CLIA-waived with an FDA-approved kit, and the radioactive 14C test is reported under CPT 78267 and 78268, not 83013.

ICD-10-CM B96.81 and the K29.0x gastritis series are the primary diagnosis codes that establish medical necessity for payers.

In Pabau, the practice management platform we build, claim validation catches missing or invalid details before an 83013 claim is submitted.

CPT code 83013: Official descriptor and clinical overview

CPT code 83013, as maintained by the American Medical Association (AMA), describes: Helicobacter pylori; breath test analysis for urease activity, non-radioactive isotope (eg, C-13). The code belongs to the Chemistry subsection of the Pathology and Laboratory section of the CPT code set.

The code captures the laboratory measurement of isotope-labeled CO2 in an exhaled breath sample, which shows whether H. pylori urease is breaking down ingested urea. It does not capture the urea drug itself, its preparation, or its administration to the patient.

How the urea breath test is performed

The urea breath test detects active H. pylori infection by measuring whether the bacteria’s urease enzyme breaks down ingested labeled urea into labeled CO2 in the patient’s breath. Knowing each step tells coders which codes apply and what the chart has to show.

1. Patient preparation: The patient fasts for at least one hour before testing. Antibiotics, bismuth compounds, and proton pump inhibitors must be stopped 2–4 weeks prior, as they suppress H. pylori activity and can produce false negatives.
2. Baseline breath collection: A baseline breath sample is collected into a collection bag or through a straw.
3. Urea administration: The patient ingests the labeled urea solution or capsule (the drug component billed under CPT 83014). FDA-approved 13C kits such as BreathTek UBT (Otsuka) hold CLIA-waived status for point-of-care use.
4. Post-dose breath collection: A second breath sample is collected at a defined interval (typically 15–30 minutes).
5. Isotope ratio analysis: The laboratory or point-of-care analyzer measures the ratio of labeled to unlabeled CO2 in the post-dose sample. This measurement is what CPT code 83013 captures.
6. Result interpretation: A positive delta-over-baseline reading confirms active H. pylori infection. The analyzer report and the physician’s interpretation note are the documentation basis for the claim.

14C vs. 13C distinction: The 14C radioisotope test follows the same clinical procedure but uses a radioactive isotope. It is not CLIA-waived, requires Nuclear Regulatory Commission licensing in some jurisdictions, and is contraindicated in pregnant women. CPT code 83013 covers the 13C test only. The 14C test is reported under CPT 78267 (acquisition of the breath sample) and CPT 78268 (analysis), not 83013.

CPT 83013 vs CPT 83014: Understanding the code pair

CPT 83013 and CPT 83014 are a commonly paired set of codes, billed together when one provider does both steps. 83013 covers the analytical measurement of the breath specimen, while 83014 covers the drug (urea) preparation and administration. The two codes serve different functions and may be billed by different providers.

When a physician’s office administers the urea and runs the in-office analyzer, both 83013 and 83014 are billed on the same claim. Sometimes the office administers the drug but sends the breath specimen to a reference laboratory. Then the office bills 83014 and the lab bills 83013 on separate claims. The diagram below maps both decisions, starting with the isotope and ending with whose claim each code goes on.

Related H. pylori test codes: When to use CPT 83013 vs alternatives

Three CPT codes cover the main non-invasive H. pylori tests, alongside the 14C breath test codes covered above. Each represents a different testing methodology with different clinical indications. Picking the wrong one is a frequent H. pylori billing error.

Coding decision: Use CPT code 83013 when the physician orders a breath test specifically. Do not substitute 83013 for 87338 (stool antigen) or 86677 (antibody serology) based on what the lab performed. The ordered and performed test must match the submitted code. A mismatch counts as upcoding or downcoding and can trigger an audit.

ICD-10 codes to pair with CPT code 83013

Payers require a diagnosis code on every 83013 claim that establishes medical necessity for the test. The ICD-10-CM codes below are common pairings, but each MAC’s LCD sets the accepted list.

Critical documentation point: The diagnosis code must reflect what is documented in the physician’s note, not what the coder infers from the order. If the note documents only “epigastric pain” (R10.13), without a gastritis or H. pylori ICD-10, some payers will deny the claim as non-covered. The physician must document the clinical indication for the test.

Medicare coverage and reimbursement for CPT 83013

Medicare covers CPT code 83013 when medical necessity is documented per the applicable Medicare Administrative Contractor (MAC) Local Coverage Determination (LCD). Coverage is not uniform nationally, because each MAC (Novitas, CGS, Palmetto, WPS, First Coast and others) sets its own LCD for H. pylori testing. Always check the LCD for your geographic jurisdiction before billing.

Each LCD for non-invasive H. pylori testing lists its covered indications, such as active peptic ulcer disease, post-treatment test-of-cure, or initial diagnosis of H. pylori-associated conditions.

How Medicare pays for CPT 83013

Medicare pays CPT 83013 under the Clinical Laboratory Fee Schedule (CLFS), not the Physician Fee Schedule. CMS updates CLFS rates annually, and the current national limit for 83013 is listed in the CMS CLFS files. Commercial payers set their own lab rates by contract.

Pabau’s billing software connects to the Claim.MD clearinghouse to submit 83013 claims electronically to thousands of US payers, including Medicare MACs. The integration supports 837P claim transmission and 835 remittance advice (ERA) receipt, so practices can match each payment to its invoice from the remittance.

Prior authorization and medical necessity requirements

Medicare generally does not require prior authorization for CPT 83013, but commercial payers vary significantly. Some Blue Cross Blue Shield plans and United Healthcare plans require prior auth for laboratory UBT testing. Meeting medical billing compliance requirements means checking each payer’s current authorization policy before the encounter, not after a denial arrives.

What documentation supports medical necessity for most payers:

• Documented symptom history (epigastric pain, nausea, early satiety) with onset and duration
• Clinical indication: Active peptic ulcer disease, dyspepsia workup, or post-treatment test-of-cure
• Documentation that endoscopy was not performed or was not indicated
• Antibiotic and PPI washout noted in the chart (confirms the test result is reliable)
• Ordering physician’s clinical rationale explicitly tied to an accepted ICD-10 pairing

Post-treatment test-of-cure: When 83013 is ordered to confirm H. pylori eradication after treatment, the chart must document the prior positive test result, the treatment regimen administered, and the minimum 4-week post-treatment interval before retesting. Missing this chain of evidence is a frequent reason eradication-confirmation claims fail medical necessity review.

Billing guidelines: Place of service, modifiers, and documentation for CPT code 83013

An incorrect place of service (POS) code can trigger an automatic denial, and it determines whether modifier QW applies. Getting medical billing fundamentals like POS selection right prevents routine 83013 rejections.

Modifier QW: CLIA waiver billing

When a physician office performs 83013 using an FDA-approved 13C kit under a CLIA waiver certificate, modifier QW must be appended to the claim. The QW modifier signals to Medicare that the test was performed as a CLIA-waived procedure. Some practices hold only a CLIA waiver, not a standard certificate. For them, submitting 83013 without QW from a POS 11 setting is a common cause of denials from Medicare and commercial payers.

Modifier 59: Distinct procedural service

Modifier 59 applies to CPT code 83013 when a same-date procedure would otherwise trigger a bundling edit (CO-97 denial). The modifier documents that the UBT is distinct from the other service and not incidental to it. Document the clinical rationale for both services in the same encounter note. For submitting a clean claim, include the modifier only when a specific edit requires it. Overuse of modifier 59 draws OIG audit attention.

Common claim denial reasons for CPT 83013 and how to avoid them

Denials on 83013 claims follow predictable patterns, and each code below comes with the documentation or coding fix to make before resubmission. A strong denial management workflow addresses these at the source rather than waiting for the EOB.

Reviewing denial reason codes in medical billing alongside your MAC’s LCD before submitting 83013 claims helps cut first-pass denials. Build a pre-submission checklist that covers ICD-10 pairing, QW modifier status, POS code, and the ordering provider NPI in Box 17 of the CMS-1500 form.

How practice management software supports accurate CPT 83013 billing

Many 83013 rejections trace back to a claim that left the office with a missing or invalid detail. Checking each claim by hand against the payer’s rules is slow, and the rejections that slip through still need chasing after the EOB arrives.

• Claim validation: Catches missing or invalid details before the claim is submitted
• Electronic submission: Sends claims through Claim.MD to thousands of US payers, including Medicare MACs
• Rejection tracking: Flags rejected claims as Needs action, so they get corrected and resubmitted
• ERA reconciliation: Matches incoming 835 remittance data against submitted claims, so payments are recorded against the invoices they cover

Pabau handles claim validation, electronic submission and rejection flagging in one claims workflow, so a practice billing CPT code 83013 sees where each claim stands. Those steps run through its claims software for practices. No software can guarantee a payer accepts a claim, so ICD-10 pairing and QW status still need a coder’s review.

Catch 83013 claim errors before submission

Pabau’s claim validation catches missing or invalid details before each 83013 claim goes out, and rejected claims land in a Needs action queue. See how it fits your lab billing workflow.

Book a demo

Conclusion

CPT code 83013 pays only when the claim matches what happened during the test. Settle the isotope first, then who ran each step, and the code choice follows from those two facts.

The trade-off sits with documentation. A breath test is quick to run but easy to lose on a missing diagnosis or modifier. The chart note deserves the same care as the claim.

Claim validation in Pabau catches missing or invalid details before submission. Rejected claims are flagged as Needs action, so your team sees which 83013 claims need fixing. Book a demo to see how it fits your lab billing workflow.

Continue your research

Need a clearinghouse that handles Medicare and commercial payers? Our Claim.MD clearinghouse guide explains how electronic claims submission reduces payment delays for lab codes like 83013.

Want to understand what makes a claim payable the first time? Clean claim submission best practices covers the fields, modifiers, and documentation that determine first-pass acceptance rates.

Seeing recurring denials across your lab codes? Revenue cycle management fundamentals explains how to build denial prevention into your front-end workflow rather than chasing EOBs.

Frequently asked questions